| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/22/2005 | US20050281787 Tumor-specific vector for gene therapy |
| 12/22/2005 | US20050281786 AAV mediated gene delivery to cochlear cells |
| 12/22/2005 | US20050281782 Novel recombinant poxvirus composition and uses thereof |
| 12/22/2005 | US20050281779 Enhancing immune responses to genetic immunization by using a chemokine |
| 12/22/2005 | US20050281719 Apparatus and method for polymer synthesis using arrays |
| 12/22/2005 | DE19605657B4 Menschliches Proinsulinderivat, Kodierende DNA, DNA enthaltender Expressionsvektor, mit diesem transformierter Mikroorganismus und Verwendung dieses menschlichen Proinsulinderivats Human proinsulin derivative-encoding DNA, DNA-containing expression vector, transformed with this microorganism and use of this human Proinsulinderivats |
| 12/22/2005 | DE10344545B4 Genetisch modifiziertes Kapsidprotein des Beak and Feather Disease Virus Genetically modified capsid protein of the Beak and Feather Disease Virus |
| 12/22/2005 | DE10333389A1 Use of cell organelles for stabilizing biomolecules and cells, useful e.g. in cell replication or in vitro translation or transcription systems, particularly mitochondria |
| 12/22/2005 | DE102004045186A1 Hydratisierte lamellare Phasen oder Liposomen, enthaltend ein Fettmonoamin oder ein kationisches Polymer, das die intrazelluläre Penetration begünstigt, und kosmetische oder pharmazeutische Zusammensetzungen, diese enthaltend, sowie Screeningverfahren nach einer solchen Substanz Hydrated lamellar phases or liposomes, containing a fatty mono-amine or a cationic polymer that promotes intracellular penetration, and cosmetic or pharmaceutical compositions comprising them, as well as screening methods for such substance |
| 12/22/2005 | DE10120797B4 Verfahren zur Analyse von Nukleinsäureketten A process for the analysis of nucleic acid chains |
| 12/22/2005 | CA2573430A1 Anti-perp antibody |
| 12/22/2005 | CA2570195A1 Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
| 12/22/2005 | CA2570033A1 The shine clade of transcription factors and their use |
| 12/22/2005 | CA2569909A1 Vaccine compositions and methods |
| 12/22/2005 | CA2569788A1 Tumor specific antibody |
| 12/22/2005 | CA2569664A1 Lipid encapsulated interfering rna |
| 12/22/2005 | CA2569645A1 Cationic lipids and methods of use |
| 12/22/2005 | CA2569511A1 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases |
| 12/22/2005 | CA2569419A1 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 12/22/2005 | CA2569036A1 Chimeric gapped oligomeric compositions |
| 12/22/2005 | CA2568995E Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 12/22/2005 | CA2568735A1 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 12/22/2005 | CA2567877A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans |
| 12/22/2005 | CA2567849A1 Non-recombinant saccharomyces strains that grow on xylose |
| 12/22/2005 | CA2567793A1 Diagnostic primers and method for detecting avian influenza virus subtype h5 and h5n1 |
| 12/22/2005 | CA2567779A1 Improved transformation of soybean |
| 12/22/2005 | CA2567087A1 Recombinant constructs for use in reducing gene expression |
| 12/22/2005 | CA2567043A1 Biosynthetic gene cluster for the production of a complex polyketide |
| 12/22/2005 | CA2565888A1 Methods for transforming and expression screening of filamentous fungal cells with a dna library |
| 12/22/2005 | CA2565124A1 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation |
| 12/22/2005 | CA2564784A1 Episomal fusion gene |
| 12/22/2005 | CA2562773A1 Cholesterol-producing yeast strains and uses thereof |
| 12/22/2005 | CA2560759A1 Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof |
| 12/22/2005 | CA2546847A1 Methods for the preparation of a fine chemical by fermentation |
| 12/22/2005 | CA2507844A1 Brassica ahas genes and gene alleles that provide resistance to imidazolinone herbicides |
| 12/22/2005 | CA2469139A1 Potato regeneration system and use thereof |
| 12/22/2005 | CA2469098A1 Pathogen inducible plant promoter and use thereof |
| 12/21/2005 | EP1607748A1 Microchip, nucleic acid extracting kit, and nucleic acid extracting method |
| 12/21/2005 | EP1607484A1 Method and circuitry for treating biological material |
| 12/21/2005 | EP1607483A1 A recombinant constructed by a virus vector and a human tumor suppressor gene and its use |
| 12/21/2005 | EP1607482A1 RNAi-based methods for selection of transfected eucaryotic cells |
| 12/21/2005 | EP1607481A1 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 12/21/2005 | EP1607480A2 Method for synthesizing DNA |
| 12/21/2005 | EP1607478A2 Chondroitin lyase enzymes |
| 12/21/2005 | EP1607477A1 Polynucleotides encoding insect acetyl coenzyme-A carboxylase and uses thereof |
| 12/21/2005 | EP1607402A1 Method for the diagnosis of tumour |
| 12/21/2005 | EP1606417A2 In vitro dna immortalization and whole genome amplification using libraries generated from randomly fragmented dna |
| 12/21/2005 | EP1606411A1 Mutant vesicular stomatitis viruses and use thereof |
| 12/21/2005 | EP1606410A2 Nucleic acid controlling the expression of a useful polypeptide in the posterior silk glands of a lepidoptera and application thereof |
| 12/21/2005 | EP1606409A2 Nogo receptor binding protein |
| 12/21/2005 | EP1606408A2 Human p53 splice variant displaying differential transcriptional activity |
| 12/21/2005 | EP1606407A2 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| 12/21/2005 | EP1606406A2 SHORT INTERFERING RNA (siRNA) ANALOGUES |
| 12/21/2005 | EP1606405A2 Compounds and their use for specific and simultaneous inhibition of genes involved in diseases and related drugs |
| 12/21/2005 | EP1606404A2 Phosphokinase assay |
| 12/21/2005 | EP1606403A2 Hemipteran glutamate decarboxylase |
| 12/21/2005 | EP1606399A2 Method of screening for target ligands |
| 12/21/2005 | EP1606398A1 Melan-a peptide analogue-virus-like-particle conjugates |
| 12/21/2005 | EP1606397A1 Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby |
| 12/21/2005 | EP1606387A2 Vectors used to create hybrid constant regions |
| 12/21/2005 | EP1606386A2 Removal of plastid sequences by transiently expressed site-specific recombinases |
| 12/21/2005 | EP1606385A2 Plant production of immunoglobulins with reduced fucosylation |
| 12/21/2005 | EP1606312A2 Baff mutants with at least one amino acid substitution and methods of their production |
| 12/21/2005 | EP1606311A1 Interferon-alpha induced gene |
| 12/21/2005 | EP1606310A2 Secreted protein family |
| 12/21/2005 | EP1606305A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 12/21/2005 | EP1606304A2 Nucleotide sequences regulating gene expression and constructs and methods utilizing same |
| 12/21/2005 | EP1606302A2 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors |
| 12/21/2005 | EP1606301A2 Aptamer therapeutics useful in ocular pharmacotherapy |
| 12/21/2005 | EP1606300A2 Sirna libraries optimized for predetermined protein families |
| 12/21/2005 | EP1606049A1 Method of synthesis and testing of combinatorial libraries using microcapsules |
| 12/21/2005 | EP1605978A2 Therapeutic compositions |
| 12/21/2005 | EP1605973A1 Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use |
| 12/21/2005 | EP1605972A2 Hiv-peptide-carrier-conjugates |
| 12/21/2005 | EP1605971A1 Immunogenic composition and methods |
| 12/21/2005 | EP1605964A1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE |
| 12/21/2005 | EP1605961A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 12/21/2005 | EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/21/2005 | EP1546333A4 Aspartyl protease inhibitor as a nematode allergen |
| 12/21/2005 | EP1539961A4 Improved transporters and their uses |
| 12/21/2005 | EP1534865A4 Methods and compositions for determining methylation profiles |
| 12/21/2005 | EP1527182A4 Process for the production of unsaturated fatty acids |
| 12/21/2005 | EP1511860A4 Improvements in and relating to a method of dna testing for------mycobacterium paratuberculosis strains |
| 12/21/2005 | EP1499738A4 Recombinase polymerase amplification |
| 12/21/2005 | EP1490496A4 Early inflorescence-preferred regulatory elements and uses thereof |
| 12/21/2005 | EP1481087A4 Zinc finger libraries |
| 12/21/2005 | EP1419237A4 Animal model for fatty acid amide-related neurobehaviors |
| 12/21/2005 | EP1404852B1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter |
| 12/21/2005 | EP1381693A4 Apparatus and method for sequencing a nucleic acid |
| 12/21/2005 | EP1373534B1 Production of genetically modified plants with puroindolines |
| 12/21/2005 | EP1337650A4 Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation |
| 12/21/2005 | EP1265916B1 Therapeutic anti-cytomegalovirus compounds |
| 12/21/2005 | EP1238067B1 Functional genomics using zinc finger proteins |
| 12/21/2005 | EP1222200B1 Fusion protein between HPV-L1 and a peptide, capable of forming a VLP and that functions as a vehicle for introduction of a peptide in a cell and medical uses thereof |
| 12/21/2005 | EP1220934B1 Methods for making recombinant proteins using apoptosis inhibitors |
| 12/21/2005 | EP1218518B1 Dna polymerase lambda and uses thereof |
| 12/21/2005 | EP1180927B1 Transformation of allium sp. with agrobacterium using embryogenic callus cultures |
| 12/21/2005 | EP1165815B1 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus |
| 12/21/2005 | EP1159426B1 Cloning and expression of haemophilus somnus transferrin-binding proteins |
| 12/21/2005 | EP1155134B1 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants |